Where it comes from, and how the question gets settled

The ways an organism reaches the gland

Two of the four categories involve bacteria that can actually be demonstrated, and for those two the question of cause has a concrete answer: something got in. The gland is not sealed off. Its ducts drain into the stretch of urethra running through it, a channel that is never sterile. Note 01 sets out the four categories if the numbering is unfamiliar.

Four routes are described. Organisms colonising the far end of the urethra can ascend it. Pressure during urination can drive urine backwards into the prostatic ducts instead of out of the body, carrying whatever it holds; a poorly emptying bladder makes that likelier. An infection already in the bladder can continue into the gland beneath it. And instrumentation opens a door directly: a catheter, a camera passed into the bladder, and above all a biopsy needle driven through the rectal wall, which carries bowel organisms across a barrier that otherwise holds them back. Infection after biopsy is a measured risk, and European guidance has spent a decade revisiting how the needle is routed.

The organisms are dull rather than exotic: overwhelmingly bowel-derived bacteria, the same family behind most ordinary urinary infections. Which species it is matters to the clinician choosing a drug and little to you. Timing matters more — a sample cultured before any antibiotic begins has a far better chance of growing something than one taken three days into a course. The organisms that inflame the urethra in younger men are a separate question with their own tests.

Many acute infections arrive with none of this: no catheter, no biopsy, no earlier infection. Having no identifiable circumstance is not evidence against the diagnosis.

The chronic form, and the explanations competing to account for it

When cultures keep coming back clean and the pain has run for months, the question stops being which organism and becomes which mechanism. Six are regularly proposed, and they are not rival theories awaiting a winner: each carries a different weight of evidence, and in most people more than one seems to be running at once.

Pelvic floor muscle dysfunction has the firmest footing. The muscular sheet across the base of the pelvis can hold itself in sustained contraction and develop tender points that refer pain to the perineum, the genitals and the rectum. Because those muscles also govern the start of urination and contract at ejaculation, an irritable pelvic floor can produce most of the symptom picture with a prostate that examines as entirely ordinary.

Nerve sensitisation comes in two forms. Peripherally, nerve endings in injured or inflamed tissue lower their firing threshold, so an ordinary stimulus produces an outsized signal. Centrally, the spinal cord and brain amplify what arrives. Standardised pressure testing has found heightened pain sensitivity at sites well away from the pelvis in some men with the chronic form, which is hard to explain by anything happening in the gland. Both terms appear in the word list.

Inflammatory and immune activity is the explanation that promised most and has aged least well. Inflammatory cells do appear in prostatic secretions in a subset of men, which is the basis of the IIIA label, but the counts track severity poorly and the same cells turn up in men who feel perfectly well. A separate group can date their symptoms to an infection that was treated and cleared: the organism has gone, the changes it set off have not.

Reflux of urine into the prostatic ducts is offered as chemical rather than bacterial irritation — urine pushed into tissue not built to hold it. The idea is old, plausible, and thinly evidenced in patients. Stress and broken sleep make the sixth strand; naming them does not imply the pain is manufactured, since both measurably alter how the nervous system handles pain signals.

None of the six is established, and more than one may apply to the same person. Nor does any of it point towards a cure: no treatment is established as a reliable cure for chronic prostatitis / chronic pelvic pain syndrome. What an assessment can do is show which mechanisms are prominent in one person.

What raises the risk, and by how much

A risk factor is a statistical companion, not a cause. It names a group in which the condition appears more often, and it may be sitting beside the real mechanism rather than driving it. The commonest history among people with this diagnosis is no notable history at all.

Two factors carry real weight for the bacterial categories, and both are mechanical. A previous urinary infection raises the chance of another, more so if it was partly treated or never cultured. Recent instrumentation — catheter, scope, biopsy — has a measured association with infection afterwards, which is why those procedures carry precautions. A bladder that never empties fully belongs in the same bracket.

The factors linked to the chronic pain form are weaker. Prolonged sitting and whole-body vibration — long-distance driving, machinery, heavy cycling — appear in questionnaire studies that depend on recall and cannot separate a cause from a consequence. Dehydration rests on reasoning rather than evidence: concentrated urine irritates. Treat it as sensible rather than proven.

A history of pelvic or lower back trouble is more interesting, since the musculature and nerve supply are shared and a protective pattern in one region recruits another readily. Sustained stress recurs throughout the literature, as do other persistent pain conditions — irritable bowel syndrome, fibromyalgia, long-running headache — which are among the most consistent associations in the field. These are a clue rather than a culprit: two or three other pain conditions make a sensitised pain system likelier, and that shifts what is worth trying first.

Things blamed for it that do not cause it

This section turns on one distinction. To cause a condition is to bring it about in someone who would not otherwise have had it; to aggravate it is to make existing symptoms temporarily worse in someone who already has it. The two get collapsed constantly.

• How often you masturbate. No threshold has been established in either direction, and nothing shows that frequency determines who develops the condition. Pain in the hours after ejaculation is a symptom of what is already there.
• Abstinence and “congestion”. The idea that fluid builds up in an unemptied gland and inflames it has no established clinical basis. It survives because it sounds mechanical and is easy to feel confirmed by.
• Spicy food, alcohol and caffeine. These sit on the trigger side of the line. Avoiding what provokes your own symptoms is reasonable, but none of the three has been shown to bring the condition about, and a man who never touches them can still develop it.
• Cycling, taken alone. Pressure on the perineum can aggravate existing pain, and a change of saddle helps some people. That is a long way from being the origin of the condition, and most regular cyclists never develop it.
• The assumption that it must be sexually transmitted. Such organisms do inflame the urethra, and testing belongs in an assessment where the history warrants it. But most prostatitis is unrelated to them, and the chronic pain form is not an infection at all.

A trigger is personal, discoverable and worth tracking; an invented cause produces guilt and no information. The fourth note sets out a method for testing your own triggers.

The sequence a careful assessment follows

No single test identifies prostatitis. The diagnosis is assembled, and the order matters, because each step narrows what the next has to consider.

The history does the heaviest lifting, and it is the part you can prepare for. A clinician wants the site of the pain and where it travels, how long it has run, what worsens and relieves it, the urinary pattern, whether ejaculation hurts, and what all of it is doing to sleep, work and mood.

Symptom scoring makes that account comparable. The standard instrument is the NIH Chronic Prostatitis Symptom Index, shortened to NIH-CPSI: nine questions on pain, urinary symptoms and quality of life, totalled out of 43. The figure means little alone; its value is in repetition, one score before a treatment starts and another a couple of months later.

Examination covers the abdomen, the genitals and a digital rectal examination, and the last is worth being plain about, since it is widely dreaded. A gloved finger in the rectum lets the clinician feel the back of the gland through a thin wall, judging its size, consistency and above all its tenderness, and check the tone of the pelvic floor at the same time. It takes under a minute. It is not a test for infection, it cannot confirm or exclude the chronic pain form, and where acute infection is suspected firm massage is deliberately avoided.

Urine testing is where the pathway forks. An organism demonstrated in a properly collected sample, in someone with the matching picture, sends everything down the bacterial branch: identify it, let the clinician choose an agent that reaches prostatic tissue, treat. Repeatedly clean cultures with three months or more of pain send everything down the non-bacterial branch, where the work becomes deciding which mechanisms are active.

What each test actually settles

What follows is a catalogue, not a programme. Few people need all of it, and which items apply depends on the history and examination that came first.

In the chronic pain form, the expected result from most of that list is normal. It is worth putting that a second way.

Why the process so often drags

Most people reading this are not at the start of the pathway. They are in the middle of it, on a third or fourth appointment, holding results that explain nothing. Few of the reasons involve anyone doing something wrong.

The conditions overlap. Bladder pain syndrome, an irritable pelvic floor, nerve irritation in the perineum, a hip or lumbar problem referring downwards and an early enlarged gland all generate much the same complaints, and several have no definitive test either. Each tends to be diagnosed by exclusion, which takes time by construction. Add the fact that the chronic form has no positive marker at all, and a run of normal results looks less like a stalled investigation than like the method working as designed.

There is also a documented pull towards repeating antibiotics. A first course sometimes seems to help, symptoms fluctuate on their own, and nobody can be certain which produced the improvement. Repeating a course that cannot work costs something in side effects and in resistance, and guidance is clear that it is the wrong move once cultures are repeatedly negative.

When progress stalls there are reasonable things to ask, and putting them as questions rather than demands tends to work better. Ask which category is being worked towards, and what would change that view. Ask what a further antibiotic course is expected to achieve, and what would count as it having failed. Ask whether a baseline symptom score exists and when it will be repeated. Ask whether the pelvic floor has been assessed, since that is frequently the omission. Ask for results in writing, and for the threshold at which referral follows.

What this note leaves out is what happens once the branch is decided. That is the next one, which sorts the treatments by the weight of evidence behind each: where antibiotics belong and where they do nothing, and which non-drug approaches have survived examination. Read note 03: treatment, sorted by strength of evidence.